» Articles » PMID: 31375927

Exploration of Serum Biomarkers for Predicting the Response to Inchinkoto (ICKT), a Japanese Traditional Herbal Medicine

Overview
Journal Metabolomics
Publisher Springer
Specialty Endocrinology
Date 2019 Aug 4
PMID 31375927
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: In patients with obstructive jaundice, biliary drainage sometimes fails to result in improvement. A pharmaceutical-grade choleretic herbal medicine, Inchinkoto (ICKT), has been proposed to exert auxiliary effects on biliary drainage; however, its effects are variable among patients.

Objectives: The aim of this study is to explore serum biomarkers that are associated with pharmaceutical efficacy of ICKT.

Methods: Obstructive jaundice patients who underwent external biliary decompression were enrolled (n = 37). ICKT was given orally 3 times a day at daily dose of 7.5 g. Serum and bile samples were collected before, 3 h after, and 24 h after ICKT administration. The concentrations of total bilirubin, direct bilirubin, and total bile acid in bile specimens were measured. Metabolites in serum samples were comprehensively profiled using LC-MS/MS and GC-MS/MS. Pharmacokinetic analysis of major ICKT components was also performed.

Results: ICKT administration significantly decreased serum ALT and increased bile volume after 24 h. The serum concentrations of ICKT components were not well correlated with the efficacy of ICKT. However, the ratio of 2-hydroxyisobutyric acid to arachidonic acid and the ratio of glutaric acid to niacinamide, exhibited good performance as biomarkers for the efficacy of ICKT on bile flow and ALT, respectively. Additionally, comprehensive correlation analysis revealed that serum glucuronic acid was highly correlated with serum total bilirubin, suggesting that this metabolite may be deeply involved in the pathogenesis of jaundice.

Conclusions: The present study indicates that ICKT is efficacious and provides candidates for predicting ICKT efficacy. Further validation studies are warranted.

Citing Articles

Inchinkoto, the Traditional Japanese Kampo Medicine, Enhances Intestinal Epithelial Barrier Function In Vitro.

Nakao A, Hu A, Yamaguchi T, Tabuchi M, Ikarashi Y, Kobayashi H Evid Based Complement Alternat Med. 2022; 2022:4139812.

PMID: 36212959 PMC: 9536930. DOI: 10.1155/2022/4139812.


BDK Deficiency in Cerebral Cortex Neurons Causes Neurological Abnormalities and Affects Endurance Capacity.

Mizusawa A, Watanabe A, Yamada M, Kamei R, Shimomura Y, Kitaura Y Nutrients. 2020; 12(8).

PMID: 32751134 PMC: 7469005. DOI: 10.3390/nu12082267.


Circulating glucuronic acid predicts healthspan and longevity in humans and mice.

Ho A, Sinick J, Esko T, Fischer K, Menni C, Zierer J Aging (Albany NY). 2019; 11(18):7694-7706.

PMID: 31557729 PMC: 6781977. DOI: 10.18632/aging.102281.


Data on metabolic profiling of healthy human subjects' plasma before and after administration of the Japanese Kampo medicine maoto.

Kitagawa H, Ohbuchi K, Munekage M, Fujisawa K, Kawanishi Y, Namikawa T Data Brief. 2019; 22:359-364.

PMID: 30596132 PMC: 6307690. DOI: 10.1016/j.dib.2018.11.116.

References
1.
Yamamoto M, Miura N, Ohtake N, Amagaya S, Ishige A, Sasaki H . Genipin, a metabolite derived from the herbal medicine Inchin-ko-to, and suppression of Fas-induced lethal liver apoptosis in mice. Gastroenterology. 2000; 118(2):380-9. DOI: 10.1016/s0016-5085(00)70220-4. View

2.
Yamashiki M, Mase A, Arai I, Huang X, Nobori T, Nishimura A . Effects of the Japanese herbal medicine 'Inchinko-to' (TJ-135) on concanavalin A-induced hepatitis in mice. Clin Sci (Lond). 2000; 99(5):421-31. View

3.
Knip M, Douek I, MOORE W, Gillmor H, McLean A, Bingley P . Safety of high-dose nicotinamide: a review. Diabetologia. 2000; 43(11):1337-45. DOI: 10.1007/s001250051536. View

4.
Kobayashi H, Horikoshi K, Yamataka A, Lane G, Yamamoto M, Miyano T . Beneficial effect of a traditional herbal medicine (inchin-ko-to) in postoperative biliary atresia patients. Pediatr Surg Int. 2001; 17(5-6):386-9. DOI: 10.1007/s003830000561. View

5.
Leu J, Crissey M, Taub R . Massive hepatic apoptosis associated with TGF-beta1 activation after Fas ligand treatment of IGF binding protein-1-deficient mice. J Clin Invest. 2003; 111(1):129-39. PMC: 151838. DOI: 10.1172/JCI16712. View